Mednet Logo
HomePediatric Hematology/OncologyQuestion

Based on recent data would you consider adding ATRA to low dose rituximab for steroid refractory ITP?

1 Answers
Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Weill Medical College of Cornell University

This is hard to answer in the absence of much more information about the patient. In a steroid refractory patient, it is important to understand why. This puts the patient immediately into a meeting refractory group (not responding to steroids). If there is an immediate need, IVIG is better. If the ...

Register or Sign In to see full answer

Based on recent data would you consider adding ATRA to low dose rituximab for steroid refractory ITP? | Mednet